Nov/Dec 2007
|
Critical Transition From Short- to Long-Acting Opioid Therapy
While most pain patients are initially treated with short-acting opioids, severe
unremitting pain involving biological manifestations requires transitioning to long-acting
opioidsłbut not on the basis of equivalency tables. Instead, long-acting opioids
should be carefully phased in at low dosages while keeping the short-acting opioid regimen
in place until it can be safely curtailed.
by Forest Tennant, MD, DrPH
|
Dysfunction and Rehabilitation of the Shoulder
Considerations of muscular relationships in pain management based on Surface
Electromyographic (SEMG) Studies.
by Gabriel E. Sella, MD
Placebos in Pain Management
A chronic pain patient’s personal perspective on the power of placebos in
mitigating chronic pain.
by Mark Collen
Publisher's Message
The Best Patient Is An Informed Patient
by Marvin Rosenfeld
Interventional Therapy: Ziconotide Combination Intrathecal Therapy
Retrospective case studies in intrathecal drug therapy patients with severe chronic
pain demonstrate the safety and efficacy of ziconotide in improving pain management while
reducing—or halting—oral and intrathecal narcotic pain medications.
by Michael J. Eastman, BA, PA-C and Steven P. Johnson, MD
Pharmacotherapy: Chronic Cancer Pain Management
Appropriate pain assessmentłalong with the proper use of opioid analgesics and the
management of common opioid side effectsłare vital components in an overall treatment
and monitoring plan.
by Charles D. Ponte, PharmD
Prolotherapy: Dextrose Prolotherapy and Pain of Chronic TMJ Dysfunction
Many of the subjective symptoms of pain, stiffness, and crunching sensation in patients
with TMJ dysfunction were reduced greater than 50% in 92% of the prolotherapy patients in
this study.
by Ross A. Hauser, MD; Marion A. Hauser, MS, RD; and Krista A. Blakemore, BA
Clinical Bioethics: The Good Patient
Responsibilities and Obligations of the Patient-Physician Relationship
by James Giordano, PhD
Head and Neck: TMJ Derangement and SUNCT Syndrome Co-Morbidity
Case report of signs and symptoms of internal derangement of the temporomandibular
joint (TMJ) co-morbid with short-lasting unilateral neuralgiform headache attacks from
conjunctival injection and tearing (SUNCT) syndrome.
by Edwin A. Ernest, III, DMD
Electromedicine: CES in the Treatment of Addictions: A Review and Meta-Analysis
Addictions are serious and poorly understood problems that may involve prescribed or
illicit drugs, alcohol, or compulsive behavioral patterns involving sex, gambling, eating
or "surfing the net." Cranial electrotherapy stimulation (CES) has been shown in
15 studies to quickly, safely and effectively reduce the physical withdrawal,
psychological cravings and co-morbid anxiety, insomnia and depression in people suffering
from addictive disorders.
by Daniel L. Kirsch, PhD, DAAPM, FAIS and Marshall F. Gilula, MD
Laser Therapy: Low Level Laser Therapy (LLLT) - Part 2
A review of seminal works on the theory of non-mechanistic, quantum physics effects of
low level energy on biological systems.
by Daniel J. Murphy, DC
HIT Advisor: Compliant Billing, Coding and Documentation for Interventional Pain
by Ted A. Arkfeld, DC, MS, CICE, CPC
|